Prediction of treatment response by anticitrullinated protein antibodies (ACPA) levels among patients with rheumatoid arthritis

by Hernández Raquel, González Paz, Muñoz Alejandro, Marenco Jose
Published 2012-11-01

The reason to stop infliximab is clearly related to the existence of new alternatives: a correspondence analysis of biologics, reasons to stop, and time periods

by Uceda Julia, Carmona Loreto, Muñoz Alejandro, Marenco Jose L
Published 2012-11-01

Clinical and functional effectiveness of anti-TNF therapy in patients with rheumatoid arthritis

by Martínez-Pérez Rosalia, Uceda Julia, León Mario, Rodríguez Sergio, Muñoz Alejandro, Gallo Francisco, Velloso Maria, Marenco Jose
Published 2011-11-01

Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis

by Martínez-Pérez Rosalía, Rodríguez-Montero Sergio, Muñoz Alejandro, Uceda Julia, León Mario, Gallo Francisco, Velloso Maria, Marenco José
Published 2012-11-01

Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis

by Martínez-Pérez Rosalía, Rodríguez-Montero Sergio, Muñoz Alejandro, Uceda Julia, León Mario, Gallo Francisco, Velloso Maria, Marenco José
Published 2011-11-01